Impact of hsCRP on heart disease patients after PCI

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the role of high-sensitivity C-reactive protein (hsCRP) in predicting the prognosis of patients with coronary artery disease (CAD) who have undergone percutaneous coronary interventions (PCI). The study will recruit patients from 14 hospitals across China and will monitor changes in hsCRP levels over one year to assess their correlation with major adverse cardiovascular and cerebrovascular events (MACCE). By understanding the residual inflammation risk (RIR) associated with hsCRP, the study seeks to provide insights into improving patient outcomes post-PCI.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants who understand and sign the informed consent voluntarily;
* Age ≥ 18 years old and ≤ 80 years old, regardless of sex;
* The hospitalized patients with coronary heart disease undergoing PCI;
* Complete all planned PCI during hospitalization.

Exclusion Criteria:

* Acute, chronic or recurrent infectious diseases;
* Immune diseases or immune-related diseases;
* Long-term use of non-steroidal anti-inflammatory drugs, hormones, immunomodulatory and chemotherapy drugs;
* Pregnant women, lactating women or women of childbearing age who do not use effective contraceptive measures;
* The researchers determined that other conditions in which the patient was not suitable to participate in the clinical trial.

Where it's running

• Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
  Wuhan, Hubei, China Recruiting

Study contacts

• Principal investigator: Xiang Cheng, Doctor — Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
• Study coordinator: Miao Yu
• Email: yumiaodavid@126.com
• Phone: +862785726009

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting Heart Muscle Recovery After CTO Revascularization

  This study looks at whether blood tests and stress echo measurements can predict which patients with CTO will regain heart muscle function after a revascularization procedure.

  Recruiting Assiut University · Asyut, Assuit · NCT07879573

• Collagen and omega-3 supplements in middle-aged women

  This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.

  Recruiting Loughborough University · Loughborough · NCT07740967

• Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women

  This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.

  Recruiting Loughborough University · Loughborough · NCT07729930

• How common dietary fats change gut bacteria and metabolic markers

  We will test whether replacing part of daily fat with butter, coconut oil, olive oil, or sunflower oil for two weeks changes gut bacteria and related blood markers in healthy adults aged 20–50.

  Recruiting University of Glasgow · Glasgow · NCT07550023

• Ginger capsules for inflammation, oxidative stress, and blood vessel health

  This trial will test whether taking a daily ginger capsule for 60 days can lower inflammation and oxidative stress and improve blood vessel function in adults with excess body fat.

  Recruiting Universidad Católica San Antonio de Murcia · Murcia, Murcia · NCT07437222

• Comparing inflammation markers from dried blood spots and standard blood draws

  This will see if finger‑prick dried blood spot samples can measure inflammation markers as accurately as standard venous blood draws in adults receiving a planned vaccine or other scheduled stressor.

  Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07435285

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.